Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
265
datasets available to search
ShareScore release 0.9.0
Dataset results
265 results for “Aromatase inhibitors”
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
ClinicalTrials.gov study NCT01160211. IPD Sharing: YES. Countries: 29. Publications: 2.
Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer
ClinicalTrials.gov study NCT03822468. IPD Sharing: YES. Countries: 23. Publications: 1.
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment.
ClinicalTrials.gov study NCT02437318. IPD Sharing: YES. Countries: 31. Publications: 6.
Flaxseed, Aromatase Inhibitors and Breast Tumor Characteristics
ClinicalTrials.gov study NCT00612560. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients Diagnosed With HR+/HER2 Advanced/Metastatic Breast Cancer on Palbociclib + Aromatase Inhibitor (AI) Combination Therapy
ClinicalTrials.gov study NCT04394247. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Faslodex +/- Concomitant Arimidex v Exemestane Following Progression on Non-steroidal Aromatase Inhibitors
ClinicalTrials.gov study NCT00253422. IPD Sharing: YES. Countries: 1. Publications: 2.
Aromatase Inhibitors and Weight Loss in Severely Obese Hypogonadal Male Veterans (Pilot)
ClinicalTrials.gov study NCT02959853. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive
ClinicalTrials.gov study NCT01491737. IPD Sharing: Not stated. Countries: 8. Publications: 1.
Aromatase Inhibitor and Durvalumab in Postmenopausal Breast Cancer
ClinicalTrials.gov study NCT03874325. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short Stature
ClinicalTrials.gov study NCT01248416. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment
ClinicalTrials.gov study NCT01573442. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)
ClinicalTrials.gov study NCT01824836. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor
ClinicalTrials.gov study NCT02340221. IPD Sharing: Not stated. Countries: 28. Publications: 2.
Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itsel
ClinicalTrials.gov study NCT06086340. IPD Sharing: NO. Countries: 1. Publications: 1.
Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy
ClinicalTrials.gov study NCT00556374. IPD Sharing: YES. Countries: 2. Publications: 5.
Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer Patients
ClinicalTrials.gov study NCT01814397. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase III Palbociclib With Endocrine Therapy vs. Capecitabine in HR+/HER2- MBC With Resistance to Aromatase Inhibitors
ClinicalTrials.gov study NCT02028507. IPD Sharing: NO. Countries: 4. Publications: 4.
Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias
ClinicalTrials.gov study NCT04754399. IPD Sharing: NO. Countries: 1. Publications: 1.
Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors
ClinicalTrials.gov study NCT01509079. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Aromatase Inhibitor Growth Study: Letrozole vs. Anastrozole
ClinicalTrials.gov study NCT02137538. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.